| | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $234,247 ) |
| | 2024 | 2024 | HEALTH, LOUISIANA DEPARTMENT OF | 1450 POYDRAS ST, STE 1652 | NEW ORLEANS | LA | 70112 | ORLEANS | USA | Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance | 00 | 3 | 7/8/2024 | NON-COMPETING CONTINUATION | $234,247 |
| | 2024 | 2023 | HEALTH, LOUISIANA DEPARTMENT OF | 1450 POYDRAS ST, STE 1652 | NEW ORLEANS | LA | 70112 | ORLEANS | USA | Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance | 00 | 3 | 7/8/2024 | NON-COMPETING CONTINUATION | $0 |
| | 2024 | 2022 | HEALTH, LOUISIANA DEPARTMENT OF | 1450 POYDRAS ST, STE 1652 | NEW ORLEANS | LA | 70112 | ORLEANS | USA | Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance | 00 | 3 | 7/8/2024 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $234,247 ) |
| | 2023 | 2023 | HEALTH, LOUISIANA DEPARTMENT OF | 1450 POYDRAS ST, STE 1652 | NEW ORLEANS | LA | 70112 | ORLEANS | USA | Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance | 00 | 2 | 6/30/2023 | NON-COMPETING CONTINUATION | $234,247 |
| | 2023 | 2022 | HEALTH, LOUISIANA DEPARTMENT OF | 1450 POYDRAS ST, STE 1652 | NEW ORLEANS | LA | 70112 | ORLEANS | USA | Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance | 00 | 2 | 6/30/2023 | NON-COMPETING CONTINUATION | $0 |
| | 2023 | 2022 | HEALTH, LOUISIANA DEPARTMENT OF | 1450 POYDRAS ST, STE 1652 | NEW ORLEANS | LA | 70112 | ORLEANS | USA | Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance | 01 | 1 | 8/1/2023 | ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS) | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $234,247 ) |
| | 2022 | 2022 | HEALTH, LOUISIANA DEPARTMENT OF | 1450 Poydras St, Ste 1652 | New Orleans | LA | 70112 | ORLEANS | USA | Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance | 00 | 1 | 7/20/2022 | NEW | $234,247 |
|
|
